Cargando…

Use of non-medical cannabis in epilepsy: A scoping review

OBJECTIVE: The use of medical cannabis among people with epilepsy (PWE) has been garnering increasing interest. In this scoping review, we aimed to summarize the literature on recreational/non-medical cannabis (NMC) use in PWE, focusing on the experience, habits, and beliefs of PWE regarding NMC. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jimmy, Areal, Cassandra C., Toffa, Dènahin Hinnoutondji, Citherlet, Daphné, Deacon, Charles, Jutras-Aswad, Didier, Keezer, Mark Robert, Nguyen, Dang Khoa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025318/
https://www.ncbi.nlm.nih.gov/pubmed/36949852
http://dx.doi.org/10.3389/fneur.2023.1132106
_version_ 1784909303367335936
author Li, Jimmy
Areal, Cassandra C.
Toffa, Dènahin Hinnoutondji
Citherlet, Daphné
Deacon, Charles
Jutras-Aswad, Didier
Keezer, Mark Robert
Nguyen, Dang Khoa
author_facet Li, Jimmy
Areal, Cassandra C.
Toffa, Dènahin Hinnoutondji
Citherlet, Daphné
Deacon, Charles
Jutras-Aswad, Didier
Keezer, Mark Robert
Nguyen, Dang Khoa
author_sort Li, Jimmy
collection PubMed
description OBJECTIVE: The use of medical cannabis among people with epilepsy (PWE) has been garnering increasing interest. In this scoping review, we aimed to summarize the literature on recreational/non-medical cannabis (NMC) use in PWE, focusing on the experience, habits, and beliefs of PWE regarding NMC. METHODS: Four databases (OVID Medline, OVID Embase, Ovid APA PsycInfo, and Web of Science) were searched for studies describing NMC use in PWE. NMC was defined as cannabis products procured from sources other than by prescription. Studies that consisted in original research and that detailed the experience, habits, and/or beliefs of PWE regarding NMC use were included in the analysis. Data pertaining to study identification, demographics, NMC use, and epilepsy characteristics were extracted. Descriptive statistical analyses and reflexive thematic analyses were performed to map these data. RESULTS: In total, 3,228 records were screened, and 66 were included for analysis: 45 had mainly adult samples, whereas 21 had mainly pediatric samples. Most studies were published after 2010, originated from the USA, and were cross-sectional. The median number of PWE using cannabis in these studies was 24.5 (1–37,945). No studies showcased elderly PWE, and most had predominantly Caucasian samples. The lifetime prevalence of NMC use in PWE was variable, ranging between 0.69 and 76.8%. Factors frequently associated with NMC use in PWE were male sex, younger adult age, and lower education status. Children with epilepsy took NMC primarily for seizure control, using high CBD/THC ratios, and only orally. Adults with epilepsy took NMC for various reasons including recreationally, using variable CBD/THC ratios, and predominantly through smoking. The majority of PWE across all studies perceived that NMC aided in seizure control. Other aspects pertaining to NMC use in PWE were rarely reported and often conflicting. CONCLUSION: The literature on NMC use in PWE is sparse and heterogeneous, with many salient knowledge gaps. Further research is necessary to better understanding the experience, habits, and beliefs of PWE pertaining to NMC.
format Online
Article
Text
id pubmed-10025318
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100253182023-03-21 Use of non-medical cannabis in epilepsy: A scoping review Li, Jimmy Areal, Cassandra C. Toffa, Dènahin Hinnoutondji Citherlet, Daphné Deacon, Charles Jutras-Aswad, Didier Keezer, Mark Robert Nguyen, Dang Khoa Front Neurol Neurology OBJECTIVE: The use of medical cannabis among people with epilepsy (PWE) has been garnering increasing interest. In this scoping review, we aimed to summarize the literature on recreational/non-medical cannabis (NMC) use in PWE, focusing on the experience, habits, and beliefs of PWE regarding NMC. METHODS: Four databases (OVID Medline, OVID Embase, Ovid APA PsycInfo, and Web of Science) were searched for studies describing NMC use in PWE. NMC was defined as cannabis products procured from sources other than by prescription. Studies that consisted in original research and that detailed the experience, habits, and/or beliefs of PWE regarding NMC use were included in the analysis. Data pertaining to study identification, demographics, NMC use, and epilepsy characteristics were extracted. Descriptive statistical analyses and reflexive thematic analyses were performed to map these data. RESULTS: In total, 3,228 records were screened, and 66 were included for analysis: 45 had mainly adult samples, whereas 21 had mainly pediatric samples. Most studies were published after 2010, originated from the USA, and were cross-sectional. The median number of PWE using cannabis in these studies was 24.5 (1–37,945). No studies showcased elderly PWE, and most had predominantly Caucasian samples. The lifetime prevalence of NMC use in PWE was variable, ranging between 0.69 and 76.8%. Factors frequently associated with NMC use in PWE were male sex, younger adult age, and lower education status. Children with epilepsy took NMC primarily for seizure control, using high CBD/THC ratios, and only orally. Adults with epilepsy took NMC for various reasons including recreationally, using variable CBD/THC ratios, and predominantly through smoking. The majority of PWE across all studies perceived that NMC aided in seizure control. Other aspects pertaining to NMC use in PWE were rarely reported and often conflicting. CONCLUSION: The literature on NMC use in PWE is sparse and heterogeneous, with many salient knowledge gaps. Further research is necessary to better understanding the experience, habits, and beliefs of PWE pertaining to NMC. Frontiers Media S.A. 2023-03-06 /pmc/articles/PMC10025318/ /pubmed/36949852 http://dx.doi.org/10.3389/fneur.2023.1132106 Text en Copyright © 2023 Li, Areal, Toffa, Citherlet, Deacon, Jutras-Aswad, Keezer and Nguyen. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Li, Jimmy
Areal, Cassandra C.
Toffa, Dènahin Hinnoutondji
Citherlet, Daphné
Deacon, Charles
Jutras-Aswad, Didier
Keezer, Mark Robert
Nguyen, Dang Khoa
Use of non-medical cannabis in epilepsy: A scoping review
title Use of non-medical cannabis in epilepsy: A scoping review
title_full Use of non-medical cannabis in epilepsy: A scoping review
title_fullStr Use of non-medical cannabis in epilepsy: A scoping review
title_full_unstemmed Use of non-medical cannabis in epilepsy: A scoping review
title_short Use of non-medical cannabis in epilepsy: A scoping review
title_sort use of non-medical cannabis in epilepsy: a scoping review
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025318/
https://www.ncbi.nlm.nih.gov/pubmed/36949852
http://dx.doi.org/10.3389/fneur.2023.1132106
work_keys_str_mv AT lijimmy useofnonmedicalcannabisinepilepsyascopingreview
AT arealcassandrac useofnonmedicalcannabisinepilepsyascopingreview
AT toffadenahinhinnoutondji useofnonmedicalcannabisinepilepsyascopingreview
AT citherletdaphne useofnonmedicalcannabisinepilepsyascopingreview
AT deaconcharles useofnonmedicalcannabisinepilepsyascopingreview
AT jutrasaswaddidier useofnonmedicalcannabisinepilepsyascopingreview
AT keezermarkrobert useofnonmedicalcannabisinepilepsyascopingreview
AT nguyendangkhoa useofnonmedicalcannabisinepilepsyascopingreview